Browsing eNauka

Browsing by Author Weber, Martin

Showing results 1 to 3 of 3
Issue DateTitleAuthor(s)TypeМp-cat.
2020A Snapshot of European Children’s Eating Habits: Results from the Fourth Round of the WHO European Childhood Obesity Surveillance Initiative (COSI)Williams, Julianne; Buoncristiano, Marta; Nardone, Paola; Rito, Ana Isabel; Spinelli, Angela; Hejgaard, Tatjana; Kierkegaard, Lene; Nurk, Eha; Kunešová, Marie; Musić, Milanović Sanja;
García-Solano, Marta; Gutiérrez-González, Enrique; Brinduse, Lacramioara Aurelia; Cucu, Alexandra; Fijałkowska, Anna; Farrugia, Sant’Angelo Victoria; Abdrakhmanova, Shynar; Pudule, Iveta; Duleva, Vesselka; Yardim, Nazan; Gualtieri, Andrea; Heinen, Mirjam; Bel-Serrat, Silvia; Usupova, Zhamyla; Peterkova, Valentina; Shengelia, Lela; Hyska, Jolanda; Tanrygulyyeva, Maya; Petrauskiene, Ausra; Rakhmatullaeva, Sanavbar; Kujundzic, Enisa; Ostojić, Sergej  ; Weghuber, Daniel; Melkumova, Marina; Spiroski, Igor; Starc, Gregor; Rutter, Harry; Rathmes, Giulia; Bunge, Anne Charlotte; Rakovac, Ivo; Boymatova, Khadichamo; Weber, Martin; Breda, João;
Научни чланак
21M21 - Водећи међународни часопис категорије M21
2023Cerebrospinal fluid and MRI analyses of fenebrutinib treatment in multiple sclerosis reveal brain penetration and early reduction of new lesion activity: results from the phase II FENopta studyBar-Or, Amit; Dufek, Michal; Budinčević, Hrvoje; Drulović, Jelena S. ; Habek, Mario; Hua, Le; Weber, Martin; Thomas, Piia; Napieralski, Julie; Clayton, David;
Kuruvilla, Denison; Qi, Qi; Xu, Yan; Goodyear, Alexandra; Oh, Jiwon;
Conference Paper
Mp. category will be shown later
2023Efficacy and Safety of Fenebrutinib, a Noncovalent, Reversible BTK inhibitor, in MS: Primary Results of a Phase 2 TrialHua, Le; Bar-Or, Amit; Weber, Martin; Habek, Mario; Budinčević, Hrvoje; Thomas, Piia; Napieralski, Julie; Ratchford, John; Qi, Qi; Sierzega, Malgorzata;
Drulović, Jelena S. ;
Конференцијски рад
Мп категорија ће бити приказана накнадно.